GL1X · GenesisL1 explorer

MolNFT v2 · #172493 · protein

Trypsin inhibitor in complex with bovine trypsin

6YIV: “Trypsin inhibitor in complex with bovine trypsin”. X-ray diffraction at 0.95, 2 ligands (D86, SO4). MolNFT v2 #172493 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6YIV
Type
protein
Length
223 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
0.95
Source
Bos taurus
UniProt
P00760
Ligands
D86, SO4

Structure

x-ray diffraction · resolution 0.95 · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein223—P00760

Ligands and binding sites

  • D86 · [azanyl(piperidin-1-yl)methylidene]azanium · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 5 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6YIV · Trypsin inhibitor in complex with bovine trypsin · the same entry in another collection · chain A against A, TM-score 1.00
  • 1TNG · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNJ · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNL · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNI · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNK · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNH · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.